National Center for Clinical Laboratories, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/National Center of Gerontology, Beijing, P.R. China.
Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China.
Clin Chem Lab Med. 2023 Jul 21;62(1):67-76. doi: 10.1515/cclm-2023-0698. Print 2024 Jan 26.
This study aims to evaluate the commutability of external quality assessment (EQA) materials and candidate reference materials (RMs) for plasma renin activity (PRA) assay.
Commutabilities of 16 candidate RMs were measured along with 40 clinical samples by the four different routine PRA assays, including three LC‒MS/MS assays and one chemiluminescence immunoassay. Sixteen candidate RMs included native/spiked human plasma pools (small-scale pools with <50 individuals) and current EQA materials (large-scale pools with >1,000 individuals). Difference in bias approach and linear regression with prediction interval approach were adopted to determine the commutability. Two-way variance analysis was used to estimate the effects of spiked and pool size on the commutability. Stability and homogeneity studies were performed.
Precision and correlation performance of all assays was acceptable. In the difference in bias approach, the commutability results were not satisfactory (noncommutability: 14/16) and significant sample-specific effects were detected in assay pairs using different incubation buffers. For the prediction interval approach, no commutability was observed in the spiked small-scale pools; EQA materials (4/9) had more satisfactory commutability among all assays than the small-scale pools (2/7); RMs of large-scale pools tend to have better commutability no matter spiked or not.
Commutable RMs were obtainable but challenging. Current EQA materials with relatively good commutability, stability, and homogeneity were appropriate RMs. Large-scale pools are tending to be commutable. Spiking in small-scale pools was not suggested to prepare RMs. MPs adopting a uniform incubation buffer would be preferable for further commutability research.
本研究旨在评估用于血浆肾素活性(PRA)测定的外部质量评估(EQA)材料和候选参考物质(RM)的互换性。
通过四种不同的常规 PRA 测定法(包括三种 LC-MS/MS 测定法和一种化学发光免疫测定法),对 16 种候选 RM 与 40 份临床样本的可互换性进行了测量。16 种候选 RM 包括天然/添加的人血浆池(个体数<50 的小池)和当前的 EQA 材料(个体数>1000 的大池)。采用偏差法和预测区间法的线性回归来确定可互换性。采用双向方差分析来估计添加物和池大小对可互换性的影响。进行了稳定性和均匀性研究。
所有测定法的精密度和相关性表现均良好。在偏差法中,可互换性结果不理想(非可互换性:16 个中的 14 个),并且在使用不同孵育缓冲液的测定对中检测到了明显的样本特异性效应。对于预测区间法,在添加的小池中的可互换性观察不到;所有测定法中,EQA 材料(9 个中的 4 个)比小池(7 个中的 2 个)的可互换性更令人满意;大池的 RM 无论是否添加,其可互换性通常更好。
虽然可获得可互换的 RM,但具有挑战性。目前具有较好可互换性、稳定性和均匀性的 EQA 材料是合适的 RM。大池倾向于可互换。不建议在小池内添加物来制备 RM。采用统一孵育缓冲液的 MPs 可能更有利于进一步的可互换性研究。